Lucia角膜假体植入术在严重角膜疾病中的结果
该回顾性介入病例系列分析了2021至2023年墨西哥城Conde de Valenciana眼科研究所48只眼植入Lucia角膜假体的并发症、功能成功和保留率。末次随访时62.5%达到功能成功(BCVA≥20/200),95.83%的假体保持在位;青光眼和术前视网膜病变与功能失败相关。
要点
- 48只眼随访平均20.5个月,末次随访62.5%达到BCVA≥20/200的功能成功。
- 至少1次术后并发症发生于75%的患者,导致65次额外干预。
- 青光眼(校正OR 469.74)和术前视网膜病变(校正OR 372.38)与功能失败相关。
核心结论
- Lucia角膜假体在严重角膜疾病中提供功能成功,并在短期至中期随访中具有优异的保留率。
研究设计与样本
- 回顾性介入病例系列,分析2021至2023年墨西哥城Conde de Valenciana眼科研究所植入Lucia角膜假体的48例患者48只眼。
主要发现
- 平均植入年龄57.29±15.63岁(范围27-91),平均随访20.5±8.83个月(范围3-40)。
- 植入诊断指征包括复发性移植排斥(54.17%)、自身免疫病(20.83%)、化学伤(12.5%)和其他(12.5%)。
- 至少1次术后并发症发生于75%的患者,导致65次额外干预(平均后续手术次数1.35±1.3,范围0-5)。
- 术前BCVA为2.40±0.36 logMAR;末次随访时62.5%达到功能成功,22.92%的BCVA达到20/40(logMAR 0.3)或更好。
- 青光眼(校正OR 469.74,95%CI 5.02-43939.14,P=.007)和术前视网膜病变(校正OR 372.38,95%CI 4.18-33162.11,P=.009)与功能失败相关;假体在95.83%的受者中保持在位。
关键数值与推荐
- 功能成功定义为最佳矫正视力(BCVA)≥20/200(logMAR 1.0)。
- 假体保留率定义为装置在位,随访期间为95.83%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Describe complications, functional success, and retention of the Lucia Keratoprosthesis (KPro). DESIGN: Retrospective interventional case series METHODS: The demographic data, baseline characteristics, complications, functional success, and retention were analyzed for Lucia KPro at the Instituto de Oftalmologia Conde de Valenciana in Mexico City from 2021 to 2023. Multivariate regression analysis and Kaplan-Meier plots were performed to identify associations with functional failure. The main outcome measures were postoperative complications, functional success defined as best-corrected visual acuity (BCVA) ≥20/200 (logMAR 1.0), and device retention rate. RESULTS: Forty-eight eyes of 48 patients (56.88% male) were studied. The mean age at implantation was 57.29 ± 15.63 years (range 27-91), with a mean follow-up of 20.5 ± 8.83 months (range 3-40). Diagnostic indications for implantation included recurrent graft rejection (54.17%), autoimmune disease (20.83%), chemical injury (12.5%), and other (12.5%). At least 1 postoperative complication occurred in 75% of patients, leading to 65 additional interventions (mean number of subsequent procedures: 1.35 ± 1.3, range 0-5). The preoperative BCVA was 2.40 ± 0.36 logMAR. At the final follow-up, 62.5% had achieved functional success and 22.92% had a BCVA of 20/40 (logMAR 0.3) or better. Glaucoma (adjusted OR 469.74, 95% CI 5.02-43939.14, P = .007) and retinal pathology before KPro (adjusted OR 372.38, 95% CI 4.18-33162.11, P = .009) were associated with functional failure. The device remained in place in 95.83% of recipients over the follow-up period. CONCLUSIONS: The Lucia KPro offers functional success in severe corneal diseases and excellent retention in the short to intermediate term.
引用
- Ortiz-Morales G, Vera-Duarte GR, Jimenez-Collado D, et al. Results of Lucia Keratoprosthesis Implantation in Severe Corneal Disease. Am J Ophthalmol. 2024. PMID: 39244000. doi:10.1016/j.ajo.2024.08.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。